QQ客服 官方微博 反馈留言

	A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway
	Kong, Zhe; Lu, Yali; Sun, Xian; Huang, Yan; Ji, Chaoneng; Li, Dujian; Luo, Jun; Gu, Wei; Wang, Chenji; Xu, Yaoting
刊名	PROSTATE
	2019
卷号	79期号:12
关键词	androgen receptor diagnosis target prostate cancer prostate-specific TP53
ISSN号	0270-4137
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3600183
专题	复旦大学上海医学院
推荐引用方式 GB/T 7714	Kong, Zhe,Lu, Yali,Sun, Xian,et al. A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway[J]. PROSTATE,2019,79(12).
APA	Kong, Zhe.,Lu, Yali.,Sun, Xian.,Huang, Yan.,Ji, Chaoneng.,...&Zhang, Yalong.(2019).A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway.PROSTATE,79(12).
MLA	Kong, Zhe,et al."A novel androgen-reduced prostate-specific lncRNA, PSLNR, inhibits prostate-cancer progression in part by regulating the p53-dependent pathway".PROSTATE 79.12(2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。